- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Maravai Lifesciences Holdings Inc (MRVI)Maravai Lifesciences Holdings Inc stock price live, this page displays NASDAQ MRVI stock exchange data. View the MRVI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Maravai Lifesciences Holdings Inc real time stock price chart below.
What Is the Maravai Lifesciences Holdings Inc Stock Price Today?
The Maravai Lifesciences Holdings Inc stock price today is 5.05.
What Is the Stock Symbol for Maravai Lifesciences Holdings Inc?
The stock symbol for Maravai Lifesciences Holdings Inc is "MRVI."
What Stock Exchange Does Maravai Lifesciences Holdings Inc Trade On?
Maravai Lifesciences Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Maravai Lifesciences Holdings Inc a Good Stock to Buy?
Determining whether Maravai Lifesciences Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRVI quote. (ISIN: US56600D1072)
What Is the Maravai Lifesciences Holdings Inc Stock Price Today?
The Maravai Lifesciences Holdings Inc stock price today is 5.05.
What Is the Stock Symbol for Maravai Lifesciences Holdings Inc?
The stock symbol for Maravai Lifesciences Holdings Inc is "MRVI."
What Stock Exchange Does Maravai Lifesciences Holdings Inc Trade On?
Maravai Lifesciences Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Maravai Lifesciences Holdings Inc a Good Stock to Buy?
Determining whether Maravai Lifesciences Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MRVI quote. (ISIN: US56600D1072)
5.05
-0.04(-0.79%)
Closed
After Hours
5.050.00(0.00%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.05
5.31
52 wk Range
4.28
11.56
MRVI Scorecard
Full Analysis
4 analysts have revised their earnings downwards for the upcoming period
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.055.31
52 wk Range
4.2811.56
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
MRVI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
9.50
Upside
+88.12%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- Maravai Lifesciences stock hits 52-week low at $4.68
- Investing.com
- Maravai Lifesciences stock hits 52-week low at $4.68
- Investing.com
Maravai Lifesciences Company Profile
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.
Maravai Lifesciences Holdings Inc SWOT Analysis
mRNA Transition | Explore Maravai LifeSciences' strategic shift beyond COVID-19, focusing on emerging opportunities in mRNA and cell and gene therapy sectors |
Financial Resilience | Discover how Maravai's Q2 2024 performance, with $73M revenue and 23% EBITDA margins, reflects its adaptability in a challenging market |
Growth Catalysts | Delve into Maravai's Flanders 2 GMP mRNA facility and CleanCap technology, poised to drive long-term sustainable growth in biotechnology |
Market Outlook | Analyst targets range from $10 to $15, reflecting varied perspectives on Maravai's potential in the evolving post-COVID bioprocessing landscape |
MRVI Full Pro Research
Institutional-Grade Stock Analysis
Understand how MRVI earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Maravai Lifesciences Holdings Inc Earnings Call Summary for Q4/2024
- Q3 revenues of $65M fell short of expectations; 2024 revenue guidance lowered to $255M-$265M due to market conditions
- $154M noncash goodwill impairment charge for TriLink; adjusted EBITDA margin forecast revised to 16%-18% for 2024
- Acquisition of Officinae Bio to enhance mRNA therapeutics capabilities; increased non-COVID mRNA clinical trial activity noted
- Key milestone: 26g mRNA material produced at Wateridge site; CleanScribe RNA Polymerase collaboration launched
- Company remains optimistic about long-term growth, citing unique technology and strategic flexibility in mRNA and gene therapies
Last Updated: 12-11-2024, 05:50 am
Read Full TranscriptCompare MRVI to Peers and Sector
Metrics to compare | MRVI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMRVIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −3.2x | −7.6x | −0.7x | |
PEG Ratio | 0.00 | −0.09 | 0.00 | |
Price/Book | 2.1x | 2.6x | 2.6x | |
Price / LTM Sales | 2.6x | 3.1x | 3.2x | |
Upside (Analyst Target) | 88.1% | 22.4% | 47.0% | |
Fair Value Upside | Unlock | 10.1% | 7.5% | Unlock |
Analysts' Recommendations
9 Buy
5 Hold
1 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 9.50
(+88.04% Upside)
FAQ
What Is the Maravai Lifesciences (MRVI) Stock Price Today?
The Maravai Lifesciences stock price today is 5.05.
What Stock Exchange Does Maravai Lifesciences Trade On?
Maravai Lifesciences is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Maravai Lifesciences?
The stock symbol for Maravai Lifesciences is "MRVI."
What Is the Maravai Lifesciences Market Cap?
As of today, Maravai Lifesciences market cap is 716.31M.
What is Maravai Lifesciences Earnings Per Share?
The Maravai Lifesciences EPS is -1.66.
What Is the Next Maravai Lifesciences Earnings Date?
Maravai Lifesciences will release its next earnings report on 18 Feb 2025.
From a Technical Analysis Perspective, Is MRVI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.